This inventor holds 2 USPTO granted patents. Top assignee: B. Braun Melsungen Ag. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: Annette Trautwein: Innovator in Extracorporeal Treatment Technologies
Introduction
Annette Trautwein is a prominent inventor based in Hassloch, Germany. She has made significant contributions to the field of medical technology, particularly in the area of extracorporeal treatment systems. With a total of 2 patents, her work focuses on innovative processes for removing harmful substances from blood and plasma.
Latest Patents
Trautwein's latest patents include a process for simultaneously removing tumor necrosis factor .alpha. (TNF.alpha.) and bacterial lipopolysaccharides (LPS) from aqueous liquids, especially blood, blood plasma, or serum. This process involves adjusting the pH value of the body fluid, adding a precipitation reagent, and removing precipitated substances through filtration or centrifugation. Additionally, she has developed a device for the extracorporeal elimination of TNF.alpha. and LPS, which utilizes both cation and anion exchanger materials within an extracorporeal perfusion system.
Career Highlights
Annette Trautwein is associated with B. Braun Melsungen AG, a leading company in the medical technology sector. Her work has been instrumental in advancing treatment options for patients requiring extracorporeal therapies.
Collaborations
Throughout her career, Trautwein has collaborated with notable colleagues, including Karl-Siegfried Boos and Dietrich Seidel. These partnerships have contributed to the development of her innovative technologies.
Conclusion
Annette Trautwein's contributions to medical technology through her patents and collaborative efforts highlight her role as a key innovator in the field. Her work continues to impact the way extracorporeal treatments are approached, improving patient outcomes.